XML 123 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Current assets      
Cash and cash equivalents $ 1,018,862 $ 1,404,160 $ 2,083,696
Restricted cash 175,321 90,413
Prepaid expenses and other current assets 319,796 366,316 249,045
Total current assets 1,513,979 1,918,439 2,332,741
Other assets 114,286  
Equipment, net 1,247 1,721 3,824
Intangible assets, net 452,490 532,010 614,386
Total assets 2,082,002 2,452,170 2,950,951
Current liabilities      
Accounts payable and accrued liabilities 1,242,237 1,394,117 2,845,381
Deferred income 28,898 10,413
Total current liabilities 1,571,135 2,615,993 4,056,844
Warrant liability 946,105 4,455,747 205,989
Other long-term liabilities 46,765 84,125 8,295
Total liabilities 3,475,468 7,155,865 4,271,128
Stockholders’ deficiency      
Common stock, value 49,009,464 39,760,287 27,956,155
Preferred stock, value 62 62  
Additional paid-in capital 18,467,705 17,288,430 15,589,229
Accumulated other comprehensive loss (104,301) (104,301) (84,728)
Accumulated deficit (68,766,396) (61,648,173) (47,884,515)
Total stockholders’ deficiency (1,393,466) (4,703,695) (1,320,177)
Total liabilities and stockholders’ deficiency 2,082,002 2,452,170 2,950,951
Related Party      
Current assets      
Related party note receivable, net 57,550
Current liabilities      
Current portion of promissory note - related party 300,000 1,211,463 1,211,463
Promissory note – related party $ 911,463  
Class A Restricted Common Shares      
Stockholders’ deficiency      
Class A restricted common shares, no par value, unlimited shares authorized, nil and 7,000,000 shares issued and outstanding as of December 31, 2023, and December 31, 2022   3,103,620
Class B Preferred Shares      
Stockholders’ deficiency      
Preferred stock, value   $ 62 $ 62